Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.06 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enriched outside the brain (oocytes) | 0.10 |
| chemistry Open Targets | reachable by antibody | 0.36 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 4607
Sealed predictions
- GFY in dopamine neurons, braak-0.34 (p 0.375) → -0.45 (p 0.230)receipt 4613
Swarm cases
receipt 4613: GFY in dopamine neurons, braak
- power
- full sample -0.43 (p 0.079, n 18), 95% CI -0.74 to +0.05. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.43 (p 0.074, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.56 (p 0.015, n 18). not the mix.
- skeptic
- leave-one-out range -0.60 to -0.36, sign flips 0; without severely affected donors -0.43 (p 0.079, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GFY in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts